Medicaid Drug Rebate Program (MDRP): A Primer
Why Should You Attend:
As part of the Patient Protection and Affordable Care Act (ACA), the Medicaid Drug Rebate Program (MDRP) underwent significant changes. The agency responsible for administering the MDRP has issued a proposed rule to implement these changes and a final rule is expected to be released in the coming months.
To assist pharmaceutical and biological companies in responding to these MDRP changes and preparing for the forthcoming guidance, this webinar will cover the basics of the MDRP for those new to government price reporting, explain the more complex concepts of the MDRP in a way all can understand, and address the most recent developments under the MDRP.
Areas Covered in the Webinar:
- The rebate formula and the Unit Rebate Amount (URA) calculation.
- Inclusions and exclusions from AMP and alternative AMPs, including AMP for “5i” and “line extension” products.
- Inclusions and exclusions from Best Price.
- The importance of class of trade designations.
- Lagged price concessions and the smoothing methodology.
- Identifying and handling bundled sales, and much more.
